Sentences with phrase «lymphoid cancers»
"Lymphoid cancers" refers to a group of cancers that start in the lymphoid tissues of the body, which play a crucial role in the immune system. These cancers can affect the lymph nodes, spleen, bone marrow, and other parts of the lymphatic system. Full definition
Facilitate cross-disciplinary research programs focused on understanding the biological mechanisms of lymphoid cancers for the development of novel therapeutic treatments for these cancers.
bccrc.ca
Centre for Lymphoid Cancer maintains provincial, national and international partnerships with multi-disciplinary scientific researchers and clinicians to:
Fully implemented targeted sequencing - based assays in routine diagnostic pathology laboratories are currently lacking in lymphoid cancer care,» explained Christian Steidl, MD, Senior Scientist at the BC Cancer and Associate Professor in the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
The investigators applied the assay to tissues from 219 patients with lymphoid cancers (114 FL, 76 DLBCL, and 29 CLL) who were treated in British Columbia, Canada, between 2013 and 2016.
We believe our study will help establish evidence - based approaches to decision making in lymphoid cancer care.
Lymphoid cancers include diffuse large B - cell lymphomas (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL), which were the focus of the present study.
The new study extends these findings to a different class of hematological cancers, namely lymphoid cancer, which is caused by abnormal activity of immune T or B cells.
The purpose of this newsletter is to provide a brief summary of the projects underway throughout our Centre for Lymphoid Cancer program, the people that work on them, and useful information on upcoming events.
Accelerate the development of novel diagnostics and therapeutics for the treatment of lymphoid cancers by fostering a cutting - edge multi-disciplinary research environment with a focus on clinical applications.
Dr. Thalheim has a special interest in Translational Medicine and Comparative Oncology, specifically involving hematopoietic and lymphoid cancers such as lymphoma and leukemia.
Some types of lymphoid cancer in dogs are also associated with virus infection.
Currently, most genetic mutations associated with lymphoid cancers have been identified.
A multi-disciplinary research program focusing on new treatments and diagnostics for lymphoid cancers
«Our developed assay harnesses the power of modern sequencing for clinical diagnostics purposes and potentially better deployment of novel treatments in lymphoid cancers.
Adaptive Biotechnologies» first test, for lymphoid cancers, also determines whether a particular treatment is effective.
The assay revealed cancer subtype - specific mutational profiles that were highly similar to published mutational profiles for all three types of lymphoid cancer.
A new study published in The Journal of Molecular Diagnostics has established that hybrid - capture sequencing is the method of choice for sequencing «actionable» gene mutations across the most common forms of lymphoid cancer.
Unlike whole - genome sequencing, this assay targets a select set of genes or regions with known associations with lymphoid cancer, allowing for more rapid detection of a variety of mutations.
«Harnessing the power of genomic sequencing augments diagnosis and treatment of lymphoid cancer: New assay may allow screening for «actionable» gene mutations in routinely acquired archival biopsies, reports The Journal of Molecular Diagnostics.»
This assay will bring the benefits of precision diagnosis and individualized therapy to patients with lymphoid cancer.
The Centre for Lymphoid Cancer is a multi-disciplinary research program focused on the development of new treatments and diagnostics for lymphoid cancers.
The Centre for Lymphoid Cancer (CLC) is composed of a lead group of research - clinicians based at the BC Cancer Agency» s Vancouver Centre and a cooperating group of 40 hemato - oncologists throughout BC that coordinate the treatment of lymphoid cancers for the province.
The mission of the Centre for Lymphoid Cancer is to better understand the biological, genetic and environmental mechanisms that cause lymphoid cancers, the determinants of their clinical behaviour and how lymphoid cancer treatments work so that more efficient diagnostic tools and therapies can be developed to combat these cancers.
The incidence of the lymphoid cancers is rising faster than any other common cancer seen in North America.
Conduct collaborative research programs to develop a more comprehensive understanding of lymphoid cancers.
Lymphoid cancers are among the most common of cancers that affect children and young adults but they can affect patients of any age or background.
Infections are important causes of lymphoid cancers.
Lymphoid cancer in the chest, tonsil or bone marrow, blood or multiple organs often progress more rapidly than those only present in lymph nodes or a single organ.
However, not all lymphoid cancers are associated with infections, so other genetic and environmental factors are also important.
«Lymphoid cancer is the most common cancer in cats making up approximately one in three cancer cases.»
Lymphoid cancer is common but does not often affect the marrow until late in the disease.
In dogs, the risk of lymphoid cancer is 13 - 24 cases of lymphosarcoma per 100,000 dogs.
Lymphoid cancer is common and the spleen may be involved along with other parts of the body.
«In cats, lymphoid cancer is the most common cancer making up approximately one in three cancer cases.»